UroToday – European Urology – Prostate Cancer Screening Decreases the
Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a
Prospective, Population-Based Randomized Controlled Trial
though the reduction in metastasis at the time of diagnosis seen in the
present study is a prerequisite for a successful prostate cancer-screening
program, the ultimate outcome in the screening studies is a difference in
prostate cancer mortality. As the very large combined screening efforts (ERSPC
and PLCO trials) are to be analyzed regarding survival in 2008, we
strongly suggest that decisions regarding large-scale screening efforts
are deferred pending these reports.
This was already a well accepted position. I agree that the important thing will be to see if it can be proven to lower mortality.